National Australia Bank Ltd to sell US operations: Is it time to buy?

National Australia Bank Ltd (ASX:NAB) will sell another stake in Great Western Bancorp to focus on its core portfolio.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

National Australia Bank Ltd (ASX: NAB) shares opened lower today, as the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) drifts mostly sideways.

The downwards movement in NAB's share price comes despite its fully-owned U.S. subsidiary, National Americas Holdings LLC, saying it will seek a secondary public offering for its shares in Great Western Bancorp.

Great Western Bancorp is an agribusiness and business bank which had, until October 2014, been fully owned by NAB.

Whilst not as bad as its UK operations, NAB's U.S. assets have long been a distraction for management.

That is until Andrew Thorburn was appointed the bank's CEO in August 2014. He has made inroads in divesting all of the bank's non-core assets outside Australia and New Zealand.

NAB has already relinquished around 30% of its ownership of Great Western Bancorp through its initial public offering (IPO) last year, but it is likely the bank will seek to rid itself of the entire holding as soon as possible.

The UK operations, where NAB owns Clydesdale and Yorkshire banks, are also believed to be up for sale.

Should you buy NAB shares now?

NAB shares have been flying in 2015 – up 15% so far. This comes despite the bank's UK subsidiaries remaining in the spotlight for all the wrong reasons and consensus forecasts for a slowdown in the domestic economy.

A slowdown wouldn't be good news for NAB, or its peers Commonwealth Bank of Australia (ASX: CBA) and Westpac Banking Corp (ASX: WBC).

Moreover, at a current price of $38.40, NAB stock doesn't come cheap. Therefore investors are advised to avoid buying shares, for now.

Motley Fool contributor Owen Raskiewicz has no position in any stocks mentioned. Owen welcomes your feedback on Google plus (see below) or you can follow him on Twitter @ASXinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »